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Infantile Cerebellar-Retinal Degeneration Associated
with a Mutation in Mitochondrial Aconitase, ACO2
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and Orly Elpeleg4,*
Degeneration of the cerebrum, cerebellum, and retina in infancy is part of the clinical spectrum of lysosomal storage disorders, mito-
chondrial respiratory chain defects, carbohydrate glycosylation defects, and infantile neuroaxonal dystrophy. We studied eight individ-
uals from two unrelated families who presented at 2–6 months of age with truncal hypotonia and athetosis, seizure disorder, and
ophthalmologic abnormalities. Their course was characterized by failure to acquire developmental milestones and culminated in
profound psychomotor retardation and progressive visual loss, including optic nerve and retinal atrophy. Despite their debilitating state,
the disease was compatible with survival of up to 18 years. Laboratory investigations were normal, but the oxidation of glutamate
by muscle mitochondria was slightly reduced. Serial brain MRI displayed progressive, prominent cerebellar atrophy accompanied by
thinning of the corpus callosum, dysmyelination, and frontal and temporal cortical atrophy. Homozygosity mapping followed by
whole-exome sequencing disclosed a Ser112Arg mutation in ACO2, encoding mitochondrial aconitase, a component of the Krebs cycle.
Specific aconitase activity in the individuals’ lymphoblasts was severely reduced. Under restrictive conditions, the mutant human ACO2
failed to complement a yeast ACO1 deletion strain, whereas the wild-type human ACO2 succeeded, indicating that this mutation is
pathogenic. Thus, a defect in mitochondrial aconitase is associated with an infantile neurodegenerative disorder affecting mainly the
cerebellum and retina. In the absence of noninvasive biomarkers, determination of the ACO2 sequence or of aconitase activity in
lymphoblasts are warranted in similarly affected individuals, based on clinical and neuroradiologic grounds.The differential diagnosis of neurodegenerative disorders
with atrophy of the cerebral and cerebellar cortex and cere-
bellar vermis is broad even in young age groups; concom-
itant occurrence of degeneration of the retina points to
lysosomal storage disorders, mitochondrial disorders,
defects of carbohydrate glycosylation, and infantile neuro-
axonal dystrophy.1–4 We hereby report on the identifica-
tion of a tricarboxylic acid (TCA) cycle defect manifesting
in infancy by the degeneration of the cerebrum, cere-
bellum, and retina.
The subjects of this study were eight individuals, two
males and six females, originating from two unrelated
families of Arab Muslim origin (Figure 1). Their clinical
data are summarized in Table 1. All were born following
an uneventful pregnancy and delivery and had normal
birth weights, head circumferences, and Apgar scores.
Symptoms were first noted at 2–6 months of age and
included variable appearance of truncal hyptonia, head
bobbing, athetosis, generalized seizures, and ophthalmo-
logic abnormalities that included strabismus, nystagmus,
abnormal eye movements, and abnormal pursuit. The
course was characterized by failure to thrive, gradual evolu-
tion of severe muscle wasting despite satisfactory oral
intake, worsening of the hypotonia, attenuating deep
tendon reflexes until complete areflexia was reached,
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to gain developmental milestones, culminating in pro-
found psychomotor retardation. A distinctive feature was
the appearance of head bobbing and athetoid movements
of the upper limbs along with horizontal nystagmus when
the individuals were held at the upright position. Visual
tracking, normal at the newborn period, steadily deterio-
rated with the gradual evolution of bilateral optic atrophy.
Visual evoked potentials in early infancy were normal, but
the electroretinogram responses became critically reduced
over the first two years of life, indicating severe retinal
dystrophy. Similarly, auditory brain responses declined
steadily, reflecting sensorineural hearing loss of variable
severity. EEG disclosed generalized or focal spike and
wave activity and slow background compatible with
nonspecific encephalopathy. Electrophysiologic assess-
ment of peripheral muscles and nerves performed in
individual V-2 at 2 years revealed a normal electromyo-
gram and a mild decrease of peripheral sensory and
motor velocity suggesting demyelination. Taken together
with the gradual disappearance of tendon reflexes, this
finding indicates an evolving peripheral demyelinating
neuropathy.
During gestation and throughout the first 6 months,
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Figure 1. Pedigrees of the Two Families
(A) Family A and (B) Family B. Affected individ-
uals are represented by filled symbols.scans (Figure 2) displayed progressive cerebellar atrophy of
both hemispheres and the vermis. In addition, symmetric
cortical atrophy gradually evolved, affecting mainly the
frontal and temporal lobes along with a striking thinning
of the corpus callosum. White matter abnormalities, indi-
cated by T2 and fluid-attenuated inversion recovery
(FLAIR) periventricular hyperintense signals, were first
noted during the second year of life. Taken together, these
serial MR scans revealed generalized progressive brain
atrophy affecting primarily the cerebellum and to a lesser
extent the white matter and the frontal and parietal lobes
of the cerebral cortex.
Extensive laboratory investigations, including complete
blood count, routine serum chemistry, glucose, lactate,
ammonia, thyroid functions, creatine kinase, acylcarni-
tines, amino acids, very long chain fatty acids, and
isoelectric focusing of transferrins, were all normal. The
profile of the urinary organic acids and specifically
aconitic, citric, and isocitric acids was normal. Cerebro-
spinal fluid analyses for cells, glucose, protein, lactate,
amino acids, and neurotransmitters were normal. Enzy-
matic assays in white blood cells excluded infantile
neuronal lipofuscinosis, GM1 gangliosidosis [MIM
230500], Tay Sachs disease [MIM 272800], Krabbe disease
[MIM 245200], and metachromatic leukodystrophy
[MIM 250100]. One individual underwent a rectal biopsy
that revealed no evidence of storage disease. Muscle
biopsies of three individuals disclosed normal histology
by light and electron microscopy and by immunohisto-
chemistry. The activities of the five enzymatic complexes
of the mitochondrial respiratory chain and the pyruvate
dehydrogenase complex were normal in isolated mito-
chondria from muscle. However, the oxidation of
glutamate was slightly reduced to 62.7% (range 57%–
66%) of the control mean, normalized to citrate synthase
activity, whereas the oxidation of the other mitochondrialThe American Journal of Hsubstrates, pyruvate, succinate, and ascor-
bate were 88.3%, 86.7%, and 90.3% of
the control mean, normalized to citrate
synthase activity, respectively.
At the time of writing, all of the individ-
uals were alive; the oldest was 18 years old
and already in a vegetative state; six individ-
uals older than 2 years were profoundly
intellectually disabled and completely
handicapped. Throughout childhood and
adolescence, the disease remained CNS
exclusive with normal results of serial echo-
cardiograms, abdominal ultrasounds, and
routine chemistry. Despite this prolonged
survival, the medical history of family Awas remarkable in that two individuals (IV-4 and IV-6)
with similar phenotype died in their first decade.
In order to localize the mutated gene, we searched for
homozygous regions common to three of the individuals
(IV-3, V-2, and V-5) by using the GeneChip Human
Mapping 250K Nsp array (Affymetrix), as previously
described.5 We then used selected short tandem repeat
(STR) markers for the genotyping of the remaining family
members. All experiments involving DNA of the individ-
uals, their relatives, and healthy controls were approved
by the Hadassah and EmekMedical Centers Ethical Review
Boards. This analysis resulted in the identification of a
single 4 Mb homozygous genomic region on chromosome
22: 38.3–42.3 Mb (corresponding to rs136805–rs6006714,
numbering according to NCBI build 36.1/hg18) encom-
passing 175 SNP markers with identical genotype. Within
this region there were 65 protein-coding genes, which
included a total of 657 exons. These data were used for
prenatal diagnosis of three pregnancies—fetus V-6 was
predicted to be heterozygous and fetuses V-1 and V-7
were predicted to be affected. The pregnancy of fetus V-1
was terminated, and postmortem pathological study was
unremarkable; in particular, brain macroscopic and micro-
scopic examinations were normal. The parents of fetus V-7
elected to continue the pregnancy, and although normal at
birth, at 6 months of age this individual already suffered
from hypotonia, developmental delay, strabismus, and
athetoid movements.
Because of the large number of genes within the region,
we performed exome sequencing. Exonic sequences in
DNA from individual V-2 were captured with the Agilent
SureSelect All Exon 50 Mb kit and sequenced on 1/4 slide
with SOLiD4. Read alignment was performed with
Bioscope, and single-nucleotide variants were called with
DiBayes and SAMtools.6 The 657 exons within the region
of homozygosity had an average read coverage of 663,uman Genetics 90, 518–523, March 9, 2012 519
Table 1. Clinical Features of Affected Individuals
Family A Family B
IV-3 IV-5 V-2 V-5 V-7 III-1 III-2 III-3
Sex m f f f m f f f
Current age (years) 18 13 7 3 0.5 9 8 2
Birth weight (centile) 2,900 g (10) 3,700 g (75) 2,700 g (10) 2,800 g (15) 3,700 g (75) 3,220 g (25) 3,450 g (50) 2,750 g (10)
Birth head
circumference (centile)
35 cm (40) 35 cm (50) 35 cm (50) 34 cm (25) 35 cm (40) 34.5 cm (40) 35 cm (50) 34 cm (25)
Initial manifestations
(age at presentation)
H, A (5 months) H, A (6 months) H, A (2 months) H, E (4 months) H, E (3 months) H, S (3 months) A, H (5 months) A, E (5 months)
Current weight (centile) 25 kg (5 SD) 26 kg (4 SD) 11 kg (5 SD) 9 kg (4 SD) 7.7 kg (25) 13 kg (6 SD) 12 kg (6 SD) 8 kg (4 SD)
Current head
circumference (centile)
47 cm (5 SD) 49.5 cm (3 SD) 46.5 cm (3.5 SD) 46.5 cm (5) 42.7 cm (25) 48.5 cm (2.5 SD) 48 cm (3) 45.5 cm (5)
Global DD/MR profound severe profound profound moderate profound profound severe
Current motor skills no intentional
movements
crawls, rolls sits
with support
does not roll rolls, does not sit lift head
when supine
does not role does not role roles both sides
Current cognitive skills vegetative state,
no smile
smile,
recognize family
smile, recognize
family
smile, recognize
family
smile, recognize
family
no eye contact,
does not recognize
family
no eye contact,
responds to
auditory stimuli
smile, recognize
family
Ataxia yes yes yes yes very mild yes yes yes
Seizures generalized generalized focal and
generalized
focal and
generalized
no generalized
myoclonic and focal
focal and
generalized
no
Retinal dystrophy
(age at diagnosis)
not evaluated severe (4 years) severe (1 year) severe (1 year) not evaluated profound (2 years) profound
(1.5 years)
moderate
(1.5 years)
ophthalmology optic atrophy,
strabismus
optic atrophy,
strabismus
optic atrophy,
nystagmus
optic atrophy,
nystagmus,
strabismus
strabismus optic atrophy,
nystagmus
optic atrophy,
nystagmus
optic atrophy,
nystagmus,
strabismus
Initial MR scan (age) not done normal
(11 months)
mild CoA
(3 months)
mild CoA (frontal
and temporal)
(11 months)
normal (in utero,
30 weeks)
CoA (frontal and
temporal) mild thinning
of CC (7 months)
CoA abnormal
WM (16 months)
normal (in utero,
31 weeks)
Last MR scan (age) not done severe CeA, moderate
CoA (frontal and
temporal), abnormal
periventricular
WM signal (12 years)
severe CeA, moderate
CoA (frontal and
temporal), thin CC
abnormal WM signal
(4 years)
severe CeA, moderate
CoA (frontal and
temporal), thin
CC, abnormal WM
signal (2.5 years)
not done not done mild CoA
and CeA (1y)
Tendon reflexes absent brisk absent absent normal absent decreased absent
Other severe scoliosis moderate SNHL severe SNHL
(hearing aids)
The following abbreviations are used: A, ataxia/athetoid movements; H, hypotonia; E, eye abnormalities; S, seizures; HC, head circumference; DD, developmental delay; MR, mental retardation; CoA, cortical atrophy; CeA,
cerebellar atrophy; WM, white matter; CC, corpus callosum; SNHL, sensorineural hearing loss.
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Figure 2. Representative MRI Findings
(A) T2-weighted, coronal section image of individual V-2
at 3 months shows a normal cerebellum andmild cortical atrophy.
(B) T1-weighted, coronal section scan of the same individual at 4
years displays severe atrophy of the cerebellar hemispheres (arrow-
heads) and the vermis (arrows).
(C) T1-weighted, coronal section image of individual IV-5 at 12
years shows enlarged cerebellar folia and reduced volume indi-
cating generalized (vermian and hemispheral) atrophy. Note also
the mild cortical atrophy and visible sulci.
(D) Cortical atrophy and white matter abnormal signals (arrows)
demonstrated by FLAIR image of coronal section in the same indi-
vidual.
(E) Moderate cortical atrophy, very thin corpus callosum (arrow),
and cerebellar atrophy (arrowhead) in a T1-weighted, sagital
section of individual V-5 at 2.5 years.
(F) FLAIR image, axial section of individual V-5 displaying frontal
and temporal cortical atrophy compared with relatively preserved
occipital cortex. The abnormal periventricular white matter signal
(arrow) is consistent with dysmyelination.
Figure 3. Aconitase-Specific Activity
Lymphoblasts from individuals harboring either a wild-type ACO2
(black bars) or a Ser112Arg-ACO2 mutated gene (grey bars) were
lysed and cell extracts were assayed for aconitase (A) and fumarase
(B) activity at the indicated temperatures. The relative specific
enzymatic activity is presented with reference to the wild-type
extract at 37C (100%). Error bars indicate the standard deviation
of two independent experiments.and 430 exons were covered more than 63. We identified
112 homozygous single-nucleotide variants in the region,
and 42 variants were located in coding exons and flanking
intronic sequencing (512 nt). Variants were further
filtered to remove polymorphisms present in dbSNP132
and the 1000 Genomes Project. Only a single coding
homozygous variant remained after filtering. This variant
was c.336C>G in ACO2 [MIM 100850] (NM_001098.2),The Amewhich causes p.Ser112Arg (NP_001089.1). This position
is highly conserved and the substitution was scored as
‘‘probably damaging’’ with PolyPhen2 (score of 0.992).
All eight individuals were homozygous for the mutation;
ten parents and one of the healthy sibs were heterozygous,
and three healthy sibs were homozygous for the
normal allele. Affected individuals of both unrelated clans
shared a similar homozygous haplotype, indicating that
Ser112Arg is a founder mutation in this population.
None of the 128 anonymous individuals of the same
ethnic origin carried the mutation.
ACO2 consists of 18 exons that encode an 805 amino
acid TCA-cycle protein, the mitochondrial aconitate hy-
dratase (mAH). Cellular aconitase activity, measured in
lymphoblasts of two individuals by monitoring the
decrease in the absorbance of the substrate cis-aconitate
at 240 nm,7 was reduced at 37C to 11.9% 5 9.2% of the
control. In contrast, fumarase activity in individuals’
lymphoblasts, assayed at 250 nm with L-malic acid as the
substrate,8 was comparable to that of the control (Figure 3).
The serine at codon 112 is highly conserved throughout
evolution, and we have used this attribute to study the
effect of the mutation in a yeast strain in which therican Journal of Human Genetics 90, 518–523, March 9, 2012 521
Figure 4. Expression of S112R mutant human mitochondrial
aconitase, ACO2, in yeast, only partially complements the deple-
tion of the endogenous aconitase, S. cerevisiae ACO1
Wild-type (WT) yeast and a mutant deleted for the aconitase gene
(Daco1) were transformed with the indicated plasmids. Cultures
were serially diluted at 10-fold intervals, and 10 ml of each was
spotted onto ethanol plates, which were incubated at 37C for
5 days.aconitase gene was deleted (Saccharomyces cerevisiae
ACO1). In yeast, a small fraction of the mAH resides in
the cytosol and has been shown to participate in the glyox-
ylate shunt that is required for growth on two-carbon
substrates such as ethanol.7 Because the human and yeast
mAHs are highly conserved, we cloned the human mAH
into a yeast expression vector and shuffled it into a yeast
strain harboring a chromosomal deletion of the yeast
mAH gene (Daco1, DYLR304C, as previously described7,8).
We found that both the nonmutated and the Ser112Arg
mutated human cDNA fully complement the yeast mAH
deletion strain under a variety of conditions (not shown).
We then examined whether the Ser112Arg mutated
human gene can complement the yeast mAH deletion
under high-requirement conditions such as respiration
and growth on two-carbon substrates. We discovered that
under growth conditions requiring the TCA cycle and
the glyoxylate shunt (growth on ethanol medium) and
growth at 37C, yeast strains expressing a Ser112Arg
mutated human gene show a very clear growth defect
(Figure 4, second row), whereas the same strain harboring
the nonmutated human ACO2 cDNA grows similarly to
the wild-type (third row). These results indicate functional
significance of the ACO2 Ser112Arg mutation, which is re-
vealed under specific physiological conditions. It is ex-
pected that a more deleterious mutation in the human
ACO2 gene would not be compatible with life because
yeast lacking the aconitase gene exhibit very severe growth
defects (Figure 4, fourth row).
Aconitate hydratase (AH) catalyzes the reversible isomer-
ization of citrate to isocitrate. The reaction consists of
dehydration followed by hydration and the formation of
an intermediate product, cis-aconitate, which normally
does not separate from AH. The two existing AH forms,
cytoplasmic (cAH) and mitochondrial (mAH), are only
30% homologous and differ from each other in physico-
chemical and structural properties. In humans, the two
forms are ubiquitously expressed and are most active in
the heart, kidney, and liver.9 Both proteins have four
iron-sulfur (Fe-S) clusters, but the fourth iron ion is loosely
bound, allowing its dissociation from the cluster thereby
rendering the protein inactive (3Fe-4S). The active522 The American Journal of Human Genetics 90, 518–523, March 9(4Fe-4S) cluster was shown to be extremely sensitive to
superoxide-mediated inactivation10 and a decrease in AH
activity was observed in several neurodegenerative diseases
associated with the development of oxidative stress, in
particular Friedreich ataxia [MIM 229300], Parkinson
[MIM 168600], and Alzheimer disease [MIM 104300],11
as well as inmice lackingmitochondrial superoxide dismu-
tase.12 The reduced AH activity in endomyocardial biopsies
of individuals with Friedreich ataxia was attributed not
only to oxidative stress but also to the importance of
Frataxin in the Fe-S cluster assembly.13 The secondary inhi-
bition of mAH in individuals with Friedreich ataxia might
thus underlie the clinical similarities with the individuals
we studied, in particular the progressive cerebellar atrophy
and the optic atrophy.14
The TCA cycle has a crucial role in energy metabolism,
generating reducing power in the form of NADH and
FADH2. Several TCA cycle enzymopaties, including defi-
ciency of succinate dehydrogenase [MIM 600857],
succinyl-CoA synthase [MIM 603921] and fumarate hydra-
tase [MIM 606812] are known to be associated with auto-
somal-recessive encephalopathies of infancy,15–18 whereas
mutations in IDH3 encoding the beta-subunit of NAD-
specific isocitrate dehydrogenase have been reported in
individuals with retinitis pigmentosa.19 The mAH defect
thus joins the growing list of neurodegenerative diseases
associated with primary TCA cycle impairment but is
distinctive in the prominent involvement of the retina
and the cerebellum. Similar to the other TCA cycle defects,
individuals in our study hardly had any mitochondrial
disease stigmata, such as elevated lactate, pyruvate, and
alanine levels in plasma or TCA cycle metabolite levels in
urine. Enzymatic activities of the mitochondrial respira-
tory chain complexes in muscle mitochondria were intact
and only glutamate oxidation was slightly reduced, indi-
cating that in clinical settings mAH deficiency would be
easily overlooked.
TCA cycle defects are not only associated with mito-
chondrial encephalopathies but also with benign and
malignant tumors; this suggests that TCA cycle metabo-
lites are in fact oncometabolites, and the enzymes
themselves are oncogene suppressors. Mutations in the
isocitrate dehydrogenase genes were found in individuals
with glioblastoma multiforme, glioma, and acute myeloid
leukemias,20 pheochromocytoma and paraganglioma were
associated with succinate dehydrogenase mutations21 and
germline mutations in the fumarate hydratase gene were
discovered in individuals with uterine fibroids, skin leio-
myomata and papillary renal cell carcinoma.22 Following
the identification of the ACO2mutation in the individuals
in our study, we scrutinized the medical files of the obliga-
tory carriers but could not identify an increased prevalence
of cancer.
Our approach, combining homozygosity mapping
with exome sequencing, enabled the identification of
a pathogenic mutation in ACO2 in eight individuals who
suffered from a neurodegenerative disorder affecting, 2012
mainly the cerebellum and the retina. As biomarkers are
not available, we recommend measurement of aconitase
activity in lymphoblasts or determination of the sequence
of ACO2 in similarly affected individuals, on the basis of
clinical and neuroradiologic grounds.Acknowledgements
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